Fruchtman Steven M 4
4 · Onconova Therapeutics, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Fruchtman Steven M
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-03-14$0.90/sh−8,727$7,854→ 74,792 total - Exercise/Conversion
Restricted Stock Units
2024-03-13−23,111→ 46,222 total→ Common Stock (23,111 underlying) - Exercise/Conversion
Common Stock
2024-03-13+23,111→ 83,519 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On March 13, 2023 the reporting person was granted 69,333 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.